Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 9 of 9 items for :

  • alpha-glucosidase inhibitor x
Clear All
Niels B Dalsgaard Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed Close
,
Lærke S Gasbjerg Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed Close
,
Laura S Hansen Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Laura S Hansen in
Google Scholar
PubMed Close
,
Dennis S Nielsen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed Close
,
Torben S Rasmussen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

course with the alpha-glucosidase inhibitor, acarbose, on GM profiles (evaluated by 16S rRNA gene-based high-throughput sequencing) in Caucasian individuals with metformin-treated T2D. Materials and methods Ethics and study approvals This

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0052
Volume/Issue:
Volume 13: Issue 7
Open access
Chunliang Yang Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Chunliang Yang in
Google Scholar
PubMed Close
,
Junyi Li Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Junyi Li in
Google Scholar
PubMed Close
,
Fei Sun The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Fei Sun in
Google Scholar
PubMed Close
,
Haifeng Zhou Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Haifeng Zhou in
Google Scholar
PubMed Close
,
Jia Yang Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Search for other papers by Jia Yang in
Google Scholar
PubMed Close
, and
Chao Yang Department of Gerontology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, China

Search for other papers by Chao Yang in
Google Scholar
PubMed Close

enteral glucose absorption (alpha-glucosidase inhibitors) and increasing renal glucose excretion (SGLT-2 inhibitors). When mono-drug therapy fails, various combinations of drug administration are required for different clinical conditions. In worsened

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0225
Volume/Issue:
Volume 9: Issue 7
Open access
Brenda Anguiano Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México

Search for other papers by Brenda Anguiano in
Google Scholar
PubMed Close
,
Carlos Montes de Oca Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México

Search for other papers by Carlos Montes de Oca in
Google Scholar
PubMed Close
,
Evangelina Delgado-González Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México

Search for other papers by Evangelina Delgado-González in
Google Scholar
PubMed Close
, and
Carmen Aceves Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México

Search for other papers by Carmen Aceves in
Google Scholar
PubMed Close

inhibits the androgenic response in LNCaP cells and reduces the invasive capacity of DU145 and PC-3 cells ( 7 ). These antitumor effects of CRYM/T3 have been explained by a reduction of T3 binding to nuclear receptors ( 7 ). Moreover, it has been proposed

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0581
Volume/Issue:
Volume 11: Issue 2
Open access
Wenrui Wang Department of Endocrinology, The Second Hospital of Jilin University, Changchun, People’s Republic of China

Search for other papers by Wenrui Wang in
Google Scholar
PubMed Close
and
Chuan Zhang Department of Endocrinology, The Second Hospital of Jilin University, Changchun, People’s Republic of China

Search for other papers by Chuan Zhang in
Google Scholar
PubMed Close

kinase; IκB, nuclear factor-kappaB inhibitor alpha; NIK, Nf-κB inducing kinase; RTK, receptor tyrosine kinases; TNF, tumor necrosis factor; TRAF2, TNF receptor-associated factor 2; RIP1, receptor-interacting protein1; MEK, MAPK kinase; MEKK, MEK kinase

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0260
Volume/Issue:
Volume 10: Issue 8
Open access
Hui-qing Yuan Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Hui-qing Yuan in
Google Scholar
PubMed Close
,
Jia-xi Miao Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Jia-xi Miao in
Google Scholar
PubMed Close
,
Jia-ping Xu Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Jia-ping Xu in
Google Scholar
PubMed Close
,
Su-xiang Zhu Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Su-xiang Zhu in
Google Scholar
PubMed Close
,
Feng Xu Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Feng Xu in
Google Scholar
PubMed Close
,
Xiao-hua Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Xiao-hua Wang in
Google Scholar
PubMed Close
,
Chun-hua Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Chun-hua Wang in
Google Scholar
PubMed Close
,
Chao Yu Department of Clinical Laboratory, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Chao Yu in
Google Scholar
PubMed Close
,
Xue-qin Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Xue-qin Wang in
Google Scholar
PubMed Close
,
Jian-bin Su Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Jian-bin Su in
Google Scholar
PubMed Close
, and
Dong-mei Zhang Medical Research Center, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed Close

-lowering therapies were acquired by searching the electronic medical record system and then were categorized into subclasses, which included insulin injections, sulfonylureas (SUs), metformin, thiazolidinediones (TZDs), α-glucosidase inhibitors (AGIs), dipeptidyl

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0597
Volume/Issue:
Volume 11: Issue 3
Open access
Jonathan Hazlehurst Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed Close
,
Bernard Khoo Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Bernard Khoo in
Google Scholar
PubMed Close
,
Carolina Brito Lobato Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark

Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed Close
,
Ibiyemi Ilesanmi Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed Close
,
Sally Abbott Department of Dietetics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Sally Abbott in
Google Scholar
PubMed Close
,
Tin Chan Faculty of Medicine, Chinese University of Hong Kong, Hong Kong

Search for other papers by Tin Chan in
Google Scholar
PubMed Close
,
Sanesh Pillai Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Sanesh Pillai in
Google Scholar
PubMed Close
,
Kate Maslin School of Nursing and Midwifery, University of Plymouth, Plymouth, UK

Search for other papers by Kate Maslin in
Google Scholar
PubMed Close
,
Sanjay Purkayastha Brunel University, London, UK
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK

Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed Close
,
Barbara McGowan Endocrinology, Guys’ and St Thomas’s NHS Foundation Trust, London, UK

Search for other papers by Barbara McGowan in
Google Scholar
PubMed Close
,
Rob Andrews University of Exeter Medical School, Exeter, UK

Search for other papers by Rob Andrews in
Google Scholar
PubMed Close
,
Eveleigh Nicholson Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed Close
,
Katherine McCullough Royal Surrey County Hospital, Guildford, UK

Search for other papers by Katherine McCullough in
Google Scholar
PubMed Close
,
Lorraine Albon University Hospitals Sussex NHS Foundation Trust, Worthing, UK

Search for other papers by Lorraine Albon in
Google Scholar
PubMed Close
,
Rachel Batterham Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Rachel Batterham in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis King's College Hospital NHS Foundation Trust, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Shareen Forbes BHF Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by Shareen Forbes in
Google Scholar
PubMed Close
,
Gavin Bewick School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Search for other papers by Gavin Bewick in
Google Scholar
PubMed Close
, and
Tricia M-M Tan Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed Close

MA . Post-gastric-bypass hypoglycemia successfully treated with alpha-glucosidase inhibitor therapy . Endocrine Practice 2013 19 511 – 514 . ( https://doi.org/10.4158/EP12281.RA ) 102 Cadegiani FA & Silva OS . Acarbose promotes remission of

Article Type:
Other
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0285
Volume/Issue:
Volume 13: Issue 5
Open access
Jukka Koffert Department of Gastroenterology, Turunmaa Hospital, Turku, Finland
Turku PET Centre, University of Turku, Turku, Finland

Search for other papers by Jukka Koffert in
Google Scholar
PubMed Close
,
Henri Honka Turku PET Centre, University of Turku, Turku, Finland

Search for other papers by Henri Honka in
Google Scholar
PubMed Close
,
Jarmo Teuho Department of Gastroenterology, Turunmaa Hospital, Turku, Finland

Search for other papers by Jarmo Teuho in
Google Scholar
PubMed Close
,
Saila Kauhanen Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland

Search for other papers by Saila Kauhanen in
Google Scholar
PubMed Close
,
Saija Hurme Institute of Biostatistics, University of Turku, Turku, Finland

Search for other papers by Saija Hurme in
Google Scholar
PubMed Close
,
Riitta Parkkola Turku PET Centre, University of Turku, Turku, Finland
Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland

Search for other papers by Riitta Parkkola in
Google Scholar
PubMed Close
,
Vesa Oikonen Turku PET Centre, University of Turku, Turku, Finland

Search for other papers by Vesa Oikonen in
Google Scholar
PubMed Close
,
Andrea Mari Institute of Neuroscience, National Research Council, Padua, Italy

Search for other papers by Andrea Mari in
Google Scholar
PubMed Close
,
Andreas Lindqvist Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed Close
,
Nils Wierup Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Nils Wierup in
Google Scholar
PubMed Close
,
Leif Groop Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden

Search for other papers by Leif Groop in
Google Scholar
PubMed Close
, and
Pirjo Nuutila Turku PET Centre, University of Turku, Turku, Finland
Department of Endocrinology, Turku University Hospital, Turku, Finland

Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed Close

of hepatic glucose cycling in glucose-intolerant or NIDDM patients . Diabetes 1991 40 73 – 81 . ( doi:10.2337/diab.40.1.73 ) 2 Holman RR. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Research

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0015
Volume/Issue:
Volume 6: Issue 3
Open access
Tatsuya Kondo Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed Close
,
Nobukazu Miyakawa Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed Close
,
Sayaka Kitano Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Sayaka Kitano in
Google Scholar
PubMed Close
,
Takuro Watanabe Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takuro Watanabe in
Google Scholar
PubMed Close
,
Rieko Goto Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Rieko Goto in
Google Scholar
PubMed Close
,
Mary Ann Suico Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Mary Ann Suico in
Google Scholar
PubMed Close
,
Miki Sato Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Miki Sato in
Google Scholar
PubMed Close
,
Yuki Takaki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Yuki Takaki in
Google Scholar
PubMed Close
,
Masaji Sakaguchi Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed Close
,
Motoyuki Igata Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Motoyuki Igata in
Google Scholar
PubMed Close
,
Junji Kawashima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Junji Kawashima in
Google Scholar
PubMed Close
,
Hiroyuki Motoshima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed Close
,
Takeshi Matsumura Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed Close
,
Hirofumi Kai Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hirofumi Kai in
Google Scholar
PubMed Close
, and
Eiichi Araki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Eiichi Araki in
Google Scholar
PubMed Close

.79 ± 5.13 Medications  Sulfnylurea N.A. N.A. 54%  Biguanide N.A. N.A. 55%  α-glucosidase inhibitor N.A. N.A. 17%  Glinide N.A. N.A. 3%  Pioglitazone N.A. N.A. 22

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0084
Volume/Issue:
Volume 10: Issue 5
Open access
Mônica R Gadelha Endocrine Unit, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close
,
Feng Gu Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China

Search for other papers by Feng Gu in
Google Scholar
PubMed Close
,
Marcello D Bronstein Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil

Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed Close
,
Thierry C Brue Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale, Marseille Medical Genetics, and Assistance Publique Hôpitaux de Marseille, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse, Marseille, France

Search for other papers by Thierry C Brue in
Google Scholar
PubMed Close
,
Maria Fleseriu Northwest Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Maria Fleseriu in
Google Scholar
PubMed Close
,
Ilan Shimon Institute of Endocrinology and Metabolism, Rabin Medical Center, and Sackler School of Medicine, Tel-Aviv University, Petah-Tiqva, Israel

Search for other papers by Ilan Shimon in
Google Scholar
PubMed Close
,
Aart J van der Lely Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Aart J van der Lely in
Google Scholar
PubMed Close
,
Shoba Ravichandran Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed Close
,
Albert Kandra Recordati AG, Basel, Switzerland

Search for other papers by Albert Kandra in
Google Scholar
PubMed Close
,
Alberto M Pedroncelli Recordati AG, Basel, Switzerland

Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed Close
, and
Annamaria A L Colao Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed Close

) OADs included dipeptidyl peptidase 4 inhibitors, sulfonylureas, meglitinides, thiazolidinediones and alpha-glucosidase inhibitors. Only two patients, both in the C2402 study, received a GLP-1 receptor agonist (liraglutide); these two patients were not

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0361
Volume/Issue:
Volume 9: Issue 12
Open access